Portal:Disease/COVIDPathways
From WikiPathways
Line 27: | Line 27: | ||
|width=100px|{{#pwImage:Pathway:WP4876|250px||Activation of NLRP3 Inflammasome by SARS-CoV-2}} | |width=100px|{{#pwImage:Pathway:WP4876|250px||Activation of NLRP3 Inflammasome by SARS-CoV-2}} | ||
Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. | Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. | ||
+ | |width=100px|{{#pwImage:Pathway:WP4877|250px||Host-pathogen interaction of human corona viruses - MAPK signaling}} | ||
|- | |- | ||
|} | |} |
Revision as of 12:59, 1 April 2020
This special subset of disease pathways is being highlighted during the current COVID-19 crisis. This content is released under a CC0 waiver to be freely used, reused and distributed. Let us know if you add a new pathway or want to recommend one for this collection. |
Image does not exist Collaborative project for curation biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. |
Image does not exist Lipid metabolism alternations that are related to infection by the corona virus. |
Image does not exist SARS-CoV-2 includes a novel Orf10 that interacts with muliple members of the Cullin 2 ubiquitin ligase complex. |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. |
Image does not exist |
Image does not exist |
Image does not exist Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. |
Image does not exist |
More about ACE2
Image does not exist |
Image does not exist |